Energy and Commerce Committee
- Referred To
Introduced: Feb 6, 2025
Latest action date: Feb 6, 2025
Latest development
Referred to the House Committee on Energy and Commerce.
Civixly approval
No ratings yet
Not enough ratings yet. Public approval appears at 5+ ratings.
Status detail: The most advanced recorded stage is committee consideration.
Plain-language overview
Modern Authentication of Pharmaceuticals Act of 2025
This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.
The bill applies to products manufactured beginning five years after the bill's enactment.
Official summary from Congress.gov.
Civixly topics
Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.
Official CRS policy area
Health
Committees and subcommittees that received, reviewed, marked up, or reported this legislation.
Proposed changes to this measure, with their latest official outcome or action from Congress.gov.
No amendments are listed for this measure.
Checked against Congress.gov Oct 22, 2026.
Newest action first. Action language comes from the official Congress.gov record.
Referred to the House Committee on Energy and Commerce.
Sponsor introductory remarks on measure. (CR H519)
Introduced in House
Introduced in House
Recorded House and Senate votes connected to this bill. Your representatives appear first when available.
No connected roll-call votes are currently available for this bill.
0 comments across 0 threads
Loading comments...